China Pharma Holdings, Inc. (OTCBB: CPHI) reported that its Q2 revenues climbed 32% to $11.3 million. Net income was up by 21% at $4 million. While these numbers are moving in the right direction, the Q2 results are less impressive than the 60% revenue growth and 78% profit increase of Q1. China Pharma makes and markets generic and branded biopharmaceuticals in China. More details...

Stock Symbol: (OTCBB: CPHI)